Stereotaxis, Inc. (STXS) is a ~$346 million market capitalization healthcare company headquartered in St. Louis, Missouri. Founded in 1990, the company makes robotic systems and instrument for treating abnormal heart rhythms in patients. The stock has had a massive run over the past couple of years, giving investors who went long the stock in April 2018 an 800% return already. I think there is greater upside potential for STXS and that investors should consider adding exposure to the company to their portfolio today. STXS equity shares should outperform in 2020, and strong IP and regulatory